Apr 16, 2025 | announcement, job offer, News, Science Communication
Mitarbeiter/in Wissenschaftskommunikation Biofaction (https://www.biofaction.com/) ist ein Wiener Unternehmen für Wissenschaftskommunikation, Technikfolgenabschätzung und Forschung, das seinen Fokus in der Vermittlung zwischen Wissenschaft, Gesellschaft, Politik,...
Apr 15, 2025 | announcement, job offer, News, Science Communication
Science Communication and Outreach Assistant Biofaction (https://www.biofaction.com/) is a Vienna-based company for science communication, technology assessment, and research that focuses on mediating between science, society, politics, art, and design. In addition to...
Apr 9, 2025 | announcement, News, publication, Science Communication
Investigating the bioelectronic potential of Physarum polycephalum Biofaction’s latest research, co-authored by Zeki Seskir and Eduardo R. Miranda, explores the electrical properties of Physarum polycephalumand its potential applications in bioelectronics. While...
Apr 9, 2025 | announcement, Film & Video, neurotechnology, News, publication, Science in Film
Exploring neurotechnology and disability through film Neurosciences and neurotechnologies are rapidly advancing and raising complex ethical and societal questions. While these developments hold promise for medical applications and enhancements alike, they also bring...
Mar 31, 2025 | AI, announcement, art residence, art-science, Events, News, Synthetic Biology
Portrait of Špela Petrič, photo credit: Anze Sekelj –PRESS RELEASE– The Bioindustry 4.0 project (https://www.bioindustry4.eu/) is pleased to announce that Špela Petrič (https://www.spelapetric.org) has been selected as the Artist-in-Residence further to an...
Feb 26, 2025 | AI, announcement, art residence, art-science, Events, News, Synthetic Biology
Last autumn we launched a Horizon Artist in Residence open call together with together with Bioart Society. The combined open call invited applications for 4 fully funded residencies across the two Horizon Europe projects deCYPher and Bioindustry 4.0. Three artists...
